Canadian VIGOUR Centre (@cvc_ualberta) 's Twitter Profile
Canadian VIGOUR Centre

@cvc_ualberta

The CVC is an academic research organization at @UAlberta dedicated to enhancing cardiovascular health. Follow us on Bluesky: tinyurl.com/34b55c5x

ID: 897880095104286720

linkhttp://www.thecvc.ca/ calendar_today16-08-2017 17:57:51

1,1K Tweet

665 Followers

962 Following

CCC Enthusiasts (@cccenthusiasts) 's Twitter Profile Photo

Now that the Altshock-2 trial is out, join us on April 23rd for an engaging journal club led by Drs. Dr. Kevin Buda and Dr. Sean van Diepen ! Will this change your practice? Still using IABP in HF-CS—or is it out the door? We can't wait to hear your thoughts in what promises to be

UArizona Sarver Heart Center (@uazheart) 's Twitter Profile Photo

Dr. Justin Ezekowitz, Professor of Medicine at UAlberta and President of the Canadian Heart Failure Society, presented at the SHC Research Seminar today #educatingleaders #cardiovascularresearch #heartfailure

Dr. Justin Ezekowitz, Professor of Medicine at UAlberta and President of the Canadian Heart Failure Society, presented at the SHC Research Seminar today #educatingleaders #cardiovascularresearch #heartfailure
Henry Han (@hancardiomd) 's Twitter Profile Photo

Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association jacc.org/doi/10.1016/j.… JACC Journals AHA Science #CCU #CICU #JACC JACC Journals

Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association

 jacc.org/doi/10.1016/j.… <a href="/JACCJournals/">JACC Journals</a> <a href="/AHAScience/">AHA Science</a> 
#CCU #CICU #JACC <a href="/JACCJournals/">JACC Journals</a>
CJC Journals (@cjcjournals) 's Twitter Profile Photo

✍️ Designing and interpreting the "small clinical trial" can be challenging. This new #review discusses advances in the field ⬇️ onlinecjc.ca/article/S0828-… Fernando Zampieri #CJC

✍️ Designing and interpreting the "small clinical trial" can be challenging. This new #review discusses advances in the field ⬇️
onlinecjc.ca/article/S0828-…
<a href="/f_g_zampieri/">Fernando Zampieri</a> #CJC
Peder L. Myhre MD, PhD (@pmyhre) 's Twitter Profile Photo

In this weeks Circulation On The Run podcast we discuss the TAP-IT trial with our brilliant guests: corr author Signe Glargaard and AE Justin Ezekowitz. Tune in🎧 podcasts.apple.com/no/podcast/cir…

CJC Journals (@cjcjournals) 's Twitter Profile Photo

🔎 Ejection systolic time, a surrogate marker of stroke volume, is an independent predictor of adverse outcomes including mortality among #STEMI patients undergoing primary #PCI. Read insights from the ARISE-STEMI study here! ⬇️ cjcopen.ca/article/S2589-… #CJCO #OpenAccess

🔎 Ejection systolic time, a surrogate marker of stroke volume, is an independent predictor of adverse outcomes including mortality among #STEMI patients undergoing primary #PCI. Read insights from the ARISE-STEMI study here! ⬇️
cjcopen.ca/article/S2589-…
#CJCO #OpenAccess
CJC Journals (@cjcjournals) 's Twitter Profile Photo

📖 Insights from the XATOA Registry: patients with #ASCVD and #HF, dual pathway inhibition demonstrated similar risks and outcomes to those observed in clinical trials. Read more ⬇️ cjcopen.ca/article/S2589-… #CJCO #OpenAccess

📖 Insights from the XATOA Registry: patients with #ASCVD and #HF, dual pathway inhibition demonstrated similar risks and outcomes to those observed in clinical trials. Read more ⬇️
cjcopen.ca/article/S2589-…
#CJCO #OpenAccess
CJC Journals (@cjcjournals) 's Twitter Profile Photo

📖 Read about renal replacement therapy in patients with cardiogenic shock — refining the AEIOUs in #cardiovascular patients ⬇️ onlinecjc.ca/article/S0828-… #CJC

📖 Read about renal replacement therapy in patients with cardiogenic shock — refining the AEIOUs in #cardiovascular patients ⬇️
onlinecjc.ca/article/S0828-…
#CJC
CJC Journals (@cjcjournals) 's Twitter Profile Photo

🫀 Read about microaxial flow pumps for mechanical circulatory support in #CardiogenicShock after #MyocardialInfarction — more #RCT needed for definitive conclusion ⬇️ onlinecjc.ca/article/S0828-… #CJC

🫀 Read about microaxial flow pumps for mechanical circulatory support in #CardiogenicShock
after #MyocardialInfarction — more #RCT needed for definitive conclusion ⬇️
onlinecjc.ca/article/S0828-…
#CJC
Canadian VIGOUR Centre (@cvc_ualberta) 's Twitter Profile Photo

Featured CJC Open article from CVC authors highlights the substantial and likely rising cost of heart failure hospitalizations in Canada, underscoring the urgent need for strategic solutions. Read here ▶️: cjcopen.ca/article/S2589-… #HeartFailureWeekCan

TheFutureEconomy.ca (@futureconomy) 's Twitter Profile Photo

Most of us don’t think about heart failure — until it touches someone we love. This year alone, an estimated 120,000 Canadians will be diagnosed with heart failure. How can we break this cycle? Read the full article from Dr. Justin Ezekowitz, President of CHFS

Canadian VIGOUR Centre (@cvc_ualberta) 's Twitter Profile Photo

New research in Journal of Allergy and Clinical Immunology: Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section. These findings highlight the need for improved asthma monitoring & management during pregnancy. Read here ➡️: sciencedirect.com/science/articl…

New research in <a href="/jacionline/">Journal of Allergy and Clinical Immunology</a>: Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, &amp; C-section. These findings highlight the need for improved asthma monitoring &amp; management during pregnancy.

Read here ➡️: sciencedirect.com/science/articl…
Libin Cardiovascular Institute (@libininstitute) 's Twitter Profile Photo

Join us on May 26 at Seton Library for our next Heart Health for Her event! This free presentation, in partnership with Calgary Public Library, features local experts sharing how menstruation, fertility, pregnancy, and menopause impact women’s heart cardiovascular health.

Join us on May 26 at Seton Library for our next Heart Health for Her event!

This free presentation, in partnership with Calgary Public Library, features local experts sharing how menstruation, fertility, pregnancy, and menopause impact women’s heart cardiovascular health.
Canadian VIGOUR Centre (@cvc_ualberta) 's Twitter Profile Photo

❣️The Spring 2025 issue of the CVC Chronicle newsletter is now available❣️ Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05/s…

❣️The Spring 2025 issue of the CVC Chronicle newsletter is now available❣️ 

Read about our current trials, research highlights, &amp; other recent news/updates here: mailchi.mp/3fed258d1c05/s…
Canadian VIGOUR Centre (@cvc_ualberta) 's Twitter Profile Photo

Dr. Padma Kaul will lead a #OneChildEveryChild program exploring how clinical, genetic, socio-economic, & behavioral factors impact neonatal & early childhood outcomes following pregnancy complications. UAlberta Med & Dent Women & Children's Health Research Institute Read more about OCEC ⬇️ ucalgary.ca/news/ucalgary-…

Heart & Stroke (@heartandstroke) 's Twitter Profile Photo

Wildfires across Canada are making for smoky air that’s not good for anyone’s health. Learn important tips from Cardiologist, Dr. Justin Ezekowitz to protect yourself and your loved ones from wildfire smoke, and share them with your friends and family.

phaware® (@phaware) 's Twitter Profile Photo

Real World Data and YOU! Dr. Jason Weatherald explains how your everyday clinic visits can help shape the future of pulmonary hypertension treatment. phaware® podcast ep 524 @phacanada #phawareMD Team PHenomenal Hope Jason Weatherald MD University of Alberta medium.com/p/im-aware-tha…

JACC Journals (@jaccjournals) 's Twitter Profile Photo

In patients with #AFib randomized to abelacimab vs. rivaroxaban, no statistically significant differences in 🩸 risk were observed, suggesting that interruption of abelacimab Tx may not be necessary before invasive procedures with low bleeding risk jacc.org/doi/10.1016/j.… #JACC

In patients with #AFib randomized to abelacimab vs. rivaroxaban, no statistically significant differences in 🩸 risk were observed, suggesting that interruption of abelacimab Tx may not be necessary before invasive procedures with low bleeding risk jacc.org/doi/10.1016/j.… #JACC